Skip to main content

Zusammenfassung

Dieses Kapitel beschäftigt sich mit der Anwendung von Photochemotherapie und Phototherapie bei Vitiligo. Zunächst wird die Krankheit definiert und werden Differentialdiagnosen und assoziierte Phänomene beschrieben. Allgemeine therapeutische Maßnahmen und Alternativen zu phototherapeutischen Verfahren folgen. Den Hauptteil bildet die Beschreibung der praktischen Durchführung und Wirkung der Bestrahlungsbehandlung mit oder ohne Photosensibilisator sowie von kombinierten Therapieformen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS (1982) An approach to the treatment of vitiligo by khellin. Dermatologica 165: 136–140.

    Article  PubMed  CAS  Google Scholar 

  • Al’Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ (1994) Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 131: 160–165.

    Article  PubMed  Google Scholar 

  • Alomar A (1992) Some new treatment of vitiligo vulgaris: phototherapy with topical khellin. In: Dermatology: progress and perspectives, 18th World Congress of Dermatology, New York, pp 517–520.

    Google Scholar 

  • Antoniou C, Katsambas A (1992) Guidelines for the treatment of vitiligo. Drugs 43: 490–498.

    Article  PubMed  CAS  Google Scholar 

  • Azmi M (1989) Vitiligo repigmentation with Polypodium leucotomos. Int J Dermatol 28: 479.

    Google Scholar 

  • Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB (1993) An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 170: 149–155.

    Article  PubMed  CAS  Google Scholar 

  • Bernd A, Ramirez-Bosca A, Huber H et al. (1995) In vitro studies on the immunomodulating effects of Polypodium leucotomos extract on human leukocyte fractions. Arzneim Forsch 45: 901–904.

    CAS  Google Scholar 

  • Bleehen SS (1976) The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies. Br J Dermatol 94 [Suppl 12]: 43–50.

    Article  PubMed  Google Scholar 

  • Brown MD, Gupta AK, Ellis CN, Rocher LL, Voorhees JJ (1989) Therapy of dermatologic disease with cyclosporin A. Adv Dermatol 4: 3–27.

    PubMed  CAS  Google Scholar 

  • Buckley DA, Rogers S (1996) Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 21: 43–45.

    Article  PubMed  CAS  Google Scholar 

  • Calanchini-Postizzi E, Frenk E (1987) Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin. Dermatologica 174: 266–271.

    Article  PubMed  CAS  Google Scholar 

  • Calzavara-Pinton PG, Carlino A, Manfredi E, Semeraro F, Zane C, De Panfilis G (1994) Ocular side effects of PUVA-treated patients refusing eye sun protection. Acta Dermatol Venereol [Suppl 186]: 164–165.

    Google Scholar 

  • Cormane RH, Siddiqui AH, Westerhof W, Schutgens RB (1985) Phenylalanine and UVA light for the treatment of vitiligo. Arch Derm Res 277: 126–130.

    Article  PubMed  CAS  Google Scholar 

  • Cox NH, Jones SK, Downey DJ, Tuyp EJ, Jay JL, Moseley H, Mackie RM (1987) Cutaneous and ocular side-effects of oral photochemotherapy: Results of an 8-year follow-up study. Br J Dermatol 116: 145–152.

    Article  PubMed  CAS  Google Scholar 

  • Cui J, Bystryn JC (1995) Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol 131: 314–318.

    Article  PubMed  CAS  Google Scholar 

  • Cui J, Arita Y, Bystryn JC (1995) Characterization of vitiligo antigens. Pigment Cell Res 8: 53–59.

    Article  PubMed  CAS  Google Scholar 

  • Duschet P, Schwarz T, Pusch M, Gschnait F (1989) Marked increase of liver transaminases after khellin and UVA therapy. J Am Acad Dermatol 21: 592–594.

    Article  PubMed  CAS  Google Scholar 

  • El Mofty AM (1948) A preliminary clinical report on the treatment of leukoderma with Ammi majus Linn. J R Egypt Med Assoc 31: 651–665.

    Google Scholar 

  • Falabella F (1988) Treatment of localized vitiligo by autologous minigrafting. Arch Dermatol 124: 1649–1655.

    Article  PubMed  CAS  Google Scholar 

  • Falabella R, Barona M, Escobar C, Borrero I, Arrunategui A (1995) Surgical combination therapy for vitiligo and piebaldism. Derm Surg 21: 852–857.

    Article  CAS  Google Scholar 

  • Frenk E (1986) Behandlung der Vitiligo. Hautarzt 37: 1–5.

    PubMed  CAS  Google Scholar 

  • Frenk E (1993) Was ist Vitiligo? Akt Dermatol 19: 77–79.

    Google Scholar 

  • Gokhale BB, Parakh AP (1983) Cyclophosphamide in vitiligo. Ind J Dermatol 28: 7–10.

    CAS  Google Scholar 

  • Gonzalez S, Pathak MA (1996) Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema, and skin photosensitization by Polypodium leucotomos. Photoderm Photoimmunol Photomed 12: 45–56.

    Article  CAS  Google Scholar 

  • Grimes PE, Minus HR, Chakrabarti SG, Enterline J, Halder R, Gough JE, Kenney JA (1982) Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol 7: 77:-778.

    Article  Google Scholar 

  • Halder RM, Battle EF, Smith EM (1995) Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol 131: 734–735.

    Article  PubMed  CAS  Google Scholar 

  • Hann SK, Cho MY, Im S, Park YK (1991) Treatment of vitiligo with oral 5-methoxypsoralen. J Dermatol 18: 324–329.

    PubMed  CAS  Google Scholar 

  • Harrist TJ, Pathak MA, Mosher DB, Fitzpatrick TB (1984) Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 66:191–196.

    PubMed  CAS  Google Scholar 

  • Kenney JA (1971) Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation. Arch Dermatol 103: 475–480.

    Google Scholar 

  • Khalid M, Mujtaba G, Haroon TS (1995) Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo. Int J Dermatol 34: 203–205.

    Article  PubMed  CAS  Google Scholar 

  • Koga M (1977) Vitiligo: a new classification and therapy. Br J Dermatol 97: 255–261.

    Article  PubMed  CAS  Google Scholar 

  • Koster W, Wiskemann A (1990) Phototherapie mit UV-B bei Vitiligo. Zeitschr Hautkrankh 65: 1022–1024.

    CAS  Google Scholar 

  • Kuiters GR, Hup JM, Siddiqui AH, Cormane RH (1986) Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. J Trop Med Hyg 89: 149–155.

    PubMed  CAS  Google Scholar 

  • Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W (1993 a) Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2: 145–153.

    Article  PubMed  Google Scholar 

  • Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK (1993b) Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100: 816–822.

    Article  PubMed  Google Scholar 

  • Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148: 1219–1228.

    PubMed  Google Scholar 

  • Lerner AB, Halaban R, Klaus SN, Moellmann GE (1987) Transplantation of human melanocytes. J Invest Dermatol 89: 219–224.

    Article  PubMed  CAS  Google Scholar 

  • Miescher G (1930) Das Problem des Lichtschutzes und der Lichtgewöhnung. Strahlentherapie 35: 403.

    Google Scholar 

  • Miyares-Cao (1986) Melagenina: ein kubanisches Produkt. Ein neues und wirksames Medikament zur Behandlung der Vitiligo (spanisch). Reihe Nationaler Berichte. Republic of Cuba, Habana, p 18.

    Google Scholar 

  • Morliere P, Honigsmann H, Averbeck D et al. (1988) Phototherapeutic, photobiologic, and photosensitizing properties of khellin. J Invest Dermatol 90: 720–724.

    Article  PubMed  CAS  Google Scholar 

  • Mosher DB, Parrish JA, Fitzpatrick TB (1977) Monobenzylether of hydroquinone: a retrospective study of 18 vitiligo patients and a review of the literature. Br J Dermatol 97: 669–679.

    Article  PubMed  CAS  Google Scholar 

  • Naughton GK, Reggiardo D, Bystryn JC (1986) Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 15: 978–981.

    Article  PubMed  CAS  Google Scholar 

  • Nordlund JJ, Halder R (1990) Melagenina. An analysis of published and other available data. Dermatologica 181: 1–4.

    CAS  Google Scholar 

  • Nordlund JJ, Ortonne JP (1992) Vitiligo and depigmentation. Curr Probl Dermatol 21: 3–29.

    Google Scholar 

  • Orecchia G, Perfetti L (1992) Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 184:120–123.

    Article  PubMed  CAS  Google Scholar 

  • Ortel B (1993) Die Photochemotherapie der Vitiligo - PUVA und KUVA. Akt Dermatol 19: 90–94.

    Google Scholar 

  • Ortel B, Tanew A, Honigsmann H (1986) Vitiligo treatment. Curr Probl Dermatol 15: 265–271.

    PubMed  CAS  Google Scholar 

  • Ortel B, Tanew A, Honigsmann H (1988) Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 18: 693–701.

    Article  PubMed  CAS  Google Scholar 

  • Ortonne JP, Mosher DB, Fitzpatrick TB (1983) Vitiligo and other hypomelanoses of the skin. Plenum, New York.

    Google Scholar 

  • Pasricha JS, Khaitan BK (1993) Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 32: 753–757.

    Article  PubMed  CAS  Google Scholar 

  • Pasricha JS, Khera V (1994) Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 33: 584–587.

    Article  PubMed  CAS  Google Scholar 

  • Pathak MA, Fitzpatrick TB (1992) The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B - Biol 14: 3–22.

    Article  CAS  Google Scholar 

  • Pathak MA, Mosher DB, Fitzpatrick TB, Parrish JA (1980) Relative effectiveness of three psoralens & sunlight in repigmentation of 365 Vitiligo patients. J Invest Dermatol 74: 252.

    Google Scholar 

  • Ronnerfalt L, Lydahl E, Wennersten G, Jahnberg P, Thyresson-Hok M (1982) Ophthalmological study of patients undergoing long-term PUVA therapy. Acta Derm Venereol 62: 501–505.

    PubMed  CAS  Google Scholar 

  • Rosenbach T, Wellenreuther U, Nürnberger F, Czarnetzki BM (1993) Behandlung der Vitiligo mit Phenylalanine und UV-A. Hautarzt 44: 208–209.

    PubMed  CAS  Google Scholar 

  • Schallreuter KU (1992) Klinik und Pathogenese der Vitiligo. In: Macher E, Kolde G, Broecker EB (eds) Jahrbuch der Dermatologie 1991/92. Biermann.

    Google Scholar 

  • Schallreuter KU, Lemke R, Brandt O et al. (1994a) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188: 269–275.

    Article  PubMed  CAS  Google Scholar 

  • Schallreuter KU, Wood JM, Pittelkow MR et al. (1994b) Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263: 1444–1446.

    Article  PubMed  CAS  Google Scholar 

  • Schallreuter KU, Wood JM, Lemke KR, Levenig C (1995) Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 190: 223–229.

    Article  PubMed  CAS  Google Scholar 

  • Schulpis CH, Antoniou C, Michas T, Strarigos J (1989) Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediat Dermatol 6: 332–335.

    Article  CAS  Google Scholar 

  • Sehgal VN (1971) Oral trimethylpsoralen in vitiligo in children: a preliminary report. Br J Dermatol 85: 454–456.

    Article  PubMed  CAS  Google Scholar 

  • SiddiquiAH, Stolk LM, Bhaggoe R, Hu R, Schütgens RB, Westerhof W (1994) L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 188: 215–218.

    Article  Google Scholar 

  • Skouge J, Morison WL (1995) Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch Dermatol 131: 1257–1258.

    Article  PubMed  CAS  Google Scholar 

  • Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Cancer 73: 2759–2764.

    Article  PubMed  CAS  Google Scholar 

  • Studniberg HM, Weller P (1993) PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 29: 1013–1022.

    Article  PubMed  CAS  Google Scholar 

  • Suite M, Quamina DB (1991) Treatment of vitiligo with topical melagenine - a human placental extract. J Am Acad Dermatol 24: 1018–1019.

    Article  PubMed  CAS  Google Scholar 

  • Szekeres E, Morvay M (1985) Repigmentation of vitiligo macules treated topically with Efudix cream. Dermatologica 171: 55–59.

    Article  PubMed  CAS  Google Scholar 

  • Tham SN, Gange RW, Parrish JA (1987) Ultraviolet-B treatment of psoriasis in patients with concomitant vitiligo. Arch Dermatol 123: 26–27.

    Article  PubMed  CAS  Google Scholar 

  • Thiele B, Steigleder GK (1987) Repigmentierungsbehandlung der Vitiligo mit L-Phenylalanine und UVA-Bestrahlung. Zeitschr Hautkrankh 62: 519–523.

    CAS  Google Scholar 

  • Tsuji T, Hamada T (1983) Topically administered fluorouracil in vitiligo. Arch Dermatol 119: 722–727.

    Article  PubMed  CAS  Google Scholar 

  • Westerhof W (1993) Differentialdiagnose bei Vitiligo - ein Bildbericht. Akt Dermatol 19: 80–86.

    Google Scholar 

  • Wildfang IL, Jacobsen FK, Thestrup-Pedersen K (1992) PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Dermatol Venereol 72: 305–306.

    CAS  Google Scholar 

  • Yagi S, Hanawa S, Morishima T (1983) Morbus Bowen und bowenoide Läsion in Vitiligohaut während prolongierter Phototherapie (japanisch). Nippon Hifuka Gakkai Zasshi - Japan J Dermatol 93: 741–745.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ortel, B., Gonzalez, S. (1997). Photo- und Photochemotherapie der Vitiligo. In: Krutmann, J., Hönigsmann, H. (eds) Handbuch der dermatologischen Phototherapie und Photodiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60425-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60425-6_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64401-6

  • Online ISBN: 978-3-642-60425-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics